DE60112956T2 - Kristalline formen von fluvastatin sodium - Google Patents
Kristalline formen von fluvastatin sodium Download PDFInfo
- Publication number
- DE60112956T2 DE60112956T2 DE60112956T DE60112956T DE60112956T2 DE 60112956 T2 DE60112956 T2 DE 60112956T2 DE 60112956 T DE60112956 T DE 60112956T DE 60112956 T DE60112956 T DE 60112956T DE 60112956 T2 DE60112956 T2 DE 60112956T2
- Authority
- DE
- Germany
- Prior art keywords
- crystalline forms
- fluvastatin sodium
- fluvastatin
- forms
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ZGGHKIMDNBDHJB-NRFPMOEYSA-M (3R,5S)-fluvastatin sodium Chemical compound [Na+].C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)=C1C1=CC=C(F)C=C1 ZGGHKIMDNBDHJB-NRFPMOEYSA-M 0.000 title 1
- 229960000868 fluvastatin sodium Drugs 0.000 title 1
- FJLGEFLZQAZZCD-MCBHFWOFSA-N (3R,5S)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-MCBHFWOFSA-N 0.000 abstract 1
- 229960003765 fluvastatin Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00811013 | 2000-10-31 | ||
| PCT/EP2001/012239 WO2002036563A1 (en) | 2000-10-31 | 2001-10-23 | Crystalline forms of fluvastatin sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60112956D1 DE60112956D1 (de) | 2005-09-29 |
| DE60112956T2 true DE60112956T2 (de) | 2006-06-14 |
Family
ID=8175001
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60112956T Expired - Fee Related DE60112956T2 (de) | 2000-10-31 | 2001-10-23 | Kristalline formen von fluvastatin sodium |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6858643B2 (de) |
| EP (1) | EP1330435B1 (de) |
| JP (1) | JP2004513112A (de) |
| CN (1) | CN1210260C (de) |
| AT (1) | ATE302756T1 (de) |
| AU (2) | AU2002223639B2 (de) |
| CA (1) | CA2426395A1 (de) |
| DE (1) | DE60112956T2 (de) |
| ES (1) | ES2247193T3 (de) |
| PL (1) | PL361061A1 (de) |
| WO (1) | WO2002036563A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1536999B (zh) * | 2001-08-03 | 2012-08-08 | 西巴特殊化学品控股有限公司 | 氟伐他汀钠的晶形 |
| AU2003276960A1 (en) * | 2002-06-13 | 2003-12-31 | Novartis Ag | Calcium salts of indole derived statins |
| US20050107359A1 (en) * | 2002-07-26 | 2005-05-19 | Van Der Schaaf Paul A. | Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| DE10316087A1 (de) * | 2003-04-08 | 2004-11-11 | Ratiopharm Gmbh | Polymorphstabilisierung von Fluvastatin-Natrium in Pharmazeutischen Formulierungen |
| WO2004096765A2 (en) * | 2003-05-01 | 2004-11-11 | Morepen Laboratories Ltd. | A novel crystalline polymorph of fluvastatin sodium and a process for preparing it |
| EP1790635A3 (de) * | 2003-06-18 | 2007-06-13 | Teva Pharmaceutical Industries, Inc. | Verfahren zur Herstellung vom amorphen Fluvastatin-Natrium |
| US7368581B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Process for the preparation of fluvastatin sodium crystal from XIV |
| US7368468B2 (en) | 2003-06-18 | 2008-05-06 | Teva Pharmaceutical Industries Ltd. | Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them |
| US7432380B2 (en) | 2003-10-16 | 2008-10-07 | Ciba Specialty Chemicals Corp. | Crystalline form of Fluvastatin sodium |
| WO2006021967A1 (en) * | 2004-08-26 | 2006-03-02 | Biocon Limited | Process for the preparation of fluvastatin sodium form a. |
| EP1634870A1 (de) * | 2004-08-27 | 2006-03-15 | Zhejiang Hisun Pharmaceutical Co. Ltd. | Verfahren und Zwischenprodukte für die selektive Herstellung von Fluvastatin |
| CA2583312A1 (en) | 2004-10-05 | 2006-04-13 | Biocon Limited | Process for the preparation of amorphous fluvastatin sodium |
| US7795451B2 (en) * | 2005-02-11 | 2010-09-14 | Jubilant Organosys Limited | Polymorphic forms of fluvastatin sodium and process for preparing the same |
| WO2006109147A1 (en) * | 2005-04-12 | 2006-10-19 | Glenmark Pharmaceuticals Limited | Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same |
| US20080027125A1 (en) * | 2006-02-27 | 2008-01-31 | Tamas Koltai | Fluvastatin sodium novel forms and preparation thereof |
| TW200901959A (en) | 2007-03-09 | 2009-01-16 | Indigene Pharmaceuticals Inc | Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications |
| US20110112053A1 (en) * | 2008-04-16 | 2011-05-12 | University Of Utah Research Foundation | Pharmacological targeting of vascular malformations |
| CN103119448A (zh) * | 2010-09-17 | 2013-05-22 | Abbvie公司 | 用于生物过程操作的拉曼光谱 |
| CN102351776B (zh) * | 2011-09-20 | 2012-09-26 | 海南美大制药有限公司 | 一种氟伐他汀钠化合物及其制法 |
| BR112015016282A2 (pt) * | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals Inc | crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4739073A (en) * | 1983-11-04 | 1988-04-19 | Sandoz Pharmaceuticals Corp. | Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof |
| DK0907639T3 (da) | 1996-06-24 | 2003-06-23 | Novartis Ag | Polymorfe forbindelser |
-
2001
- 2001-10-23 ES ES01992698T patent/ES2247193T3/es not_active Expired - Lifetime
- 2001-10-23 AT AT01992698T patent/ATE302756T1/de not_active IP Right Cessation
- 2001-10-23 PL PL01361061A patent/PL361061A1/xx not_active Application Discontinuation
- 2001-10-23 CN CNB01818278XA patent/CN1210260C/zh not_active Expired - Fee Related
- 2001-10-23 AU AU2002223639A patent/AU2002223639B2/en not_active Ceased
- 2001-10-23 US US10/130,043 patent/US6858643B2/en not_active Expired - Fee Related
- 2001-10-23 WO PCT/EP2001/012239 patent/WO2002036563A1/en active IP Right Grant
- 2001-10-23 EP EP01992698A patent/EP1330435B1/de not_active Expired - Lifetime
- 2001-10-23 CA CA002426395A patent/CA2426395A1/en not_active Abandoned
- 2001-10-23 AU AU2363902A patent/AU2363902A/xx active Pending
- 2001-10-23 JP JP2002539323A patent/JP2004513112A/ja not_active Withdrawn
- 2001-10-23 DE DE60112956T patent/DE60112956T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002036563A1 (en) | 2002-05-10 |
| AU2363902A (en) | 2002-05-15 |
| US20030125569A1 (en) | 2003-07-03 |
| DE60112956D1 (de) | 2005-09-29 |
| US6858643B2 (en) | 2005-02-22 |
| CA2426395A1 (en) | 2002-05-10 |
| EP1330435A1 (de) | 2003-07-30 |
| PL361061A1 (en) | 2004-09-20 |
| JP2004513112A (ja) | 2004-04-30 |
| CN1210260C (zh) | 2005-07-13 |
| ATE302756T1 (de) | 2005-09-15 |
| AU2002223639B2 (en) | 2006-06-22 |
| CN1473151A (zh) | 2004-02-04 |
| EP1330435B1 (de) | 2005-08-24 |
| ES2247193T3 (es) | 2006-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60112956D1 (de) | Kristalline formen von fluvastatin sodium | |
| NO20043367L (no) | Oralt farmasoytisk preparat | |
| EA201000643A1 (ru) | Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе | |
| SE0101675D0 (sv) | Novel composition | |
| EA200601773A1 (ru) | Тетраазабензо[е]азуленовые производные и их аналоги | |
| DE60225040D1 (de) | Montelukast-granulatformulierung | |
| IS6859A (is) | Kristölluð form atorvastatíns | |
| BG66085B1 (bg) | Фенилаланинови производни | |
| BR0207640A (pt) | Composição farmacêutica oral de cefpodoxima proxetil | |
| BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
| ME00454B (me) | Nova so perindoprila i farmaceutske kompozicije koje sadrže tu so | |
| BR0311189A (pt) | Composições farmacêuticas contendo polimorfo a de flibanserin | |
| HUP0401141A2 (hu) | A fluvasztatin-nátrium kristályos formái, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| CY1105039T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ ΕΝΩΣΕΙΣ ΒΕΝΖΟ[b]ΑΖΕΠΙΝ-2-ΟΝΗΣ | |
| BR0311984A (pt) | Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação | |
| TNSN06012A1 (en) | Emulsifying systems containing azetidine derivatives | |
| IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| SE9901077D0 (sv) | Novel use | |
| EE05085B1 (et) | Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks | |
| EE200200252A (et) | Antikehade kasutamine vaktsiinidena, antikehi sisaldavad farmatseutilised kompositsioonid, meetod antikehapreparaadi valmistamiseks ja meetod farmatseutilise kompositsiooni valmistamiseks | |
| EA200700203A1 (ru) | Фармацевтическая композиция, содержащая габапентин | |
| BR0016638B1 (pt) | compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la. | |
| BR0315620A (pt) | Derivados de n-benzodioxolil, n-benzodioxanil e n-benzodioxepinil arilcarboxamida, e composições farmacêuticas compreendendo os mesmos | |
| EA200201024A1 (ru) | Фармацевтические композиции, содержащие олигосахариды, и их получение | |
| EA200300556A1 (ru) | Композиция n-(метилэтиламинокарбонил)-4-(3-метилфениламино)-3-пиридилсульфонамида и циклических олигосахаридов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |